Peptide Category · 4 entries

GLP-1 Receptor Agonists

Semaglutide, Tirzepatide, Liraglutide. Long-acting GLP-1 (and dual GLP-1/GIP) receptor agonists with weekly or daily SubQ dosing. Used for type-2 diabetes, weight loss, appetite regulation. Black-box risk: medullary thyroid carcinoma and MEN2.

Peptides in this category

Liraglutidet½ 2 hours
SubQ · GLP-1
Also: Saxenda, Victoza
Retatrutidet½ 6 days
SubQ · GLP-1
Also: LY3437943, Triple Hormone Receptor Agonist, Reta
Semaglutidet½ 7 days
SubQ, Oral · GLP-1
Also: Ozempic, Wegovy, Rybelsus
Tirzepatidet½ 5 days
SubQ · GLP-1
Also: Mounjaro, Zepbound, LY3298176

Outcome protocols using GLP-1 peptides

Fat Loss (Lipolysis)
Accelerate fat metabolism and lipolysis without affecting growth hormone levels
Blood Sugar
Regulate blood glucose levels and improve glycemic control
Appetite Suppression
Reduce appetite and support weight management goals
Insulin Sensitivity
Improve cellular response to insulin and metabolic health
Cardio Health
Support cardiovascular function and vascular health